Facilitating early detection and treatment
of prevalent, chronic and progressive
Meibomian Gland Disease (MGD).
Now you can easily visualize and identify MGD with gland function and structure in minutes, and treat it efficiently with the TearScience® Solution for MGD.
As a surgeon, I recognize the importance of optimizing the ocular surface and the long term consequences of not treating MGD...
MGD is a chronic, progressive disease affecting approximately 300 million people worldwide. MGD is characterized by terminal duct obstruction and/or changes in the glandular secretion.